Montara Therapeutics Launches with $8M to Develop Safer Neurological Therapeutics

Company Launch::
Montara Therapeutics has debuted with a focus on developing safer neurological therapeutics.

Funding::
The company has secured $8 million in seed funding to support its research and development efforts.

BrainOnly Platform::
Montara Therapeutics has revealed its BrainOnly platform, which is designed to provide a dual therapeutic approach.

Mission::
The company aims to create safer and more effective treatments for neurological disorders.

Recent Announcement::
The details of the BrainOnly platform and the seed funding were announced on July 30, 2024.